OBJECTIVE Nontraumatic intracerebral hemorrhage (ICH) is a potentially devastating
cerebrovascular disorder. Several randomized trials have assessed interventions to improve …

Optimal antithrombotic management after intracerebral hemorrhage remains one of the
central unresolved issues for patients who survive, especially for those patients with atrial …

Background Cardiogenic shock secondary to acute myocardial infarction (AMI-CS) is
associated with substantial short-term mortality; however, there are limited data on long-term …

Background We investigated incidence and outcome of spontaneous intracerebral
hemorrhage (ICH) in a population‐based stroke registry and provided data to inform on the …

Statins lower low-density lipoprotein cholesterol and are widely used for the prevention of
atherosclerotic cardiovascular disease. Whether statin-induced low-density lipoprotein …

Background Macrophages are innate immune cells whose phagocytosis function is critical to
the prognosis of stroke and peritonitis. cis-aconitic decarboxylase immune-responsive gene …

Intracerebral hemorrhage (ICH) stands as one of the most daunting challenges in the field of
neurosurgery and neurocritical care. The incidence of ICH is 29.9 per 100 000 person-years …

Background: Recent years have seen a change in the use of anticoagulants in the general
population due to the availability of direct oral anticoagulants (DOACs) as an alternative to …

Objective Inflammation participates in the pathology and progression of secondary brain
injury after intracerebral hemorrhage (ICH). This meta-analysis intended to explore the …

Objective To assess the prevalence and factors associated with early cognitive impairment
in intracerebral hemorrhage (ICH) patients and to describe short‐term recovery trajectories …